임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
15건 표시
- 해당없음모집 예정· HER2+ Metastatic Breast Cancer (MBC)Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
협력: 화이자
- 해당없음모집 중· Hematopoietic and Lymphatic System NeoplasmA Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California
협력: 화이자
- 해당없음모집 중· Cardiovascular DiseasesBEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
협력: 얀센(J&J), 노보노디스크, 화이자, 다케다
- 해당없음모집 중· ALK+ Non-Small-Cell Lung CarcinomaAnalysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
리드: 화이자
- 해당없음모집 예정· Metastatic Breast CancerCollaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)
협력: 화이자
- 해당없음모집 중· Androgen Deprivation TherapyExercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
협력: 화이자
- 해당없음모집 중단 (진행 중)· Lung CancerImplementation Strategies for Monitoring Adherence in Real Time
협력: 화이자
- 해당없음모집 중· Amyloidosis TransthyretinQuantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis
협력: 화이자
- 해당없음모집 중· Transthyretin AmyloidosisPrevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
협력: 화이자
- 해당없음모집 중단 (진행 중)· Breast Cancer Stage IVLocoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients
협력: 화이자
- 해당없음모집 중단 (진행 중)· Non-alcoholic Fatty Liver DiseaseRole of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
협력: 화이자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.